Adjuvant Transarterial chemoembolization does not influence recurrence-free or overall survival in patients with combined hepatocellular carcinoma and Cholangiocarcinoma after curative resection: a propensity score matching analysis

BACKGROUND: The prognosis of patients with combined hepatocellular carcinoma and intrahepatic cholangiocarcinoma (CHC) is usually poor, and effective adjuvant therapy is missing making it important to investigate whether these patients may benefit from adjuvant transarterial chemoembolization (TACE)...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Wei-Ren, Tian, Meng-Xin, Tao, Chen-Yang, Tang, Zheng, Zhou, Yu-Fu, Song, Shu-Shu, Jiang, Xi-Fei, Wang, Han, Zhou, Pei-Yun, Qu, Wei-Feng, Fang, Yuan, Ding, Zhen-Bin, Zhou, Jian, Fan, Jia, Shi, Ying-Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7350756/
https://www.ncbi.nlm.nih.gov/pubmed/32650743
http://dx.doi.org/10.1186/s12885-020-07138-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7350756/
https://www.ncbi.nlm.nih.gov/pubmed/32650743
http://dx.doi.org/10.1186/s12885-020-07138-z

Ejemplares similares